Imbalance towards the GIP receptor, combined with distinct signaling properties at the GLP-1 receptor, together may account for the promising efficacy of tirzepatide as observed in various cell models, isolated islets, and perfused pancreas (86)
ZEPBOUND INDICATIONS AND SAFETY SUMMARY WITH WARNINGS Zepbound (ZEHP-bownd) is an injectable prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with: obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off
Legitimate prescription medications clearly state the active ingredient (semaglutide or tirzepatide), include dosing instructions in micrograms, and come from licensed pharmacies with verifiable credentials
Important safety considerations for transdermal patches: Avoid applying external heat (such as heating pads, hot water bottles, electric blankets, or prolonged sun exposure) to the patch area, as this may increase drug absorption and side effects Do not cut patches or apply additional adhesives unless specifically instructed to do so Wash hands thoroughly after handling patches to avoid transferring medication to eyes or mucous membranes For patients currently using licensed injectable GLP-1 receptor agonists, continue to follow the administration instructions provided in the PIL and by your healthcare team